A novel phenotyping strategy in schizophrenia, targeting different neurocognitive domains, neurobehavioral features, and selected personality traits, has allowed us to identify a homogeneous familial subtype of the disease, characterized by pervasive neurocognitive deficit. Our genome scan data indicate that this subtype, which accounts for up to 50% of our sample, has a distinct genetic basis and explains linkage to chromosome 6p24 reported previously. If representative of other populations, the ratio of schizophrenia subtypes observed in our families could have a profound impact on sample heterogeneity and on the power of genetic studies to detect linkage and association. Our proposed abbreviated battery of tests should facilitate phenotype characterization for future genetic analyses and allow a focus on a crisply defined schizophrenia subtype, thus promoting a more informed search for susceptibility genes.
The inherent heterogeneity of the original concept has been obfuscated in modern diagnostic classifications (DSM-IV and ICD-10), which are designed to meet the needs of patient management, not fundamental research; which give primacy to subjective symptoms; and which may not target phenotypes anchored in the biology of the illness (Heinrichs 2004) . Limited understanding of phenotypic heterogeneity is a common challenge in genetic studies of complex disorders and is a major contributor to the slow progress of such studies. The search for susceptibility genes in schizophrenia is particularly aggravated by the dual predicament of likely etiological diversity and a potentially fallible phenotype based on the diagnostic classifications of psychopathological phenomena.
In this study, we adopted, from the outset, the original concept (Bleuler 1920 ) of schizophrenia as an amalgam of several underlying, etiologically distinct disorders, and we argue that objective measures of brain dysfunction are likely to facilitate their delineation. Recent evidence has indicated that patients with schizophrenia exhibit abnormalities in multiple cognitive domains that predate the onset of the disorder (Kremen et al. 1998; Bilder et al. 2000) , persist across changes in the clinical state (Hoff et al. 1999) , are not attributable to antipsychotic medications (Torrey 2002) , occur in nonpsychotic relatives (Sitskoorn et al. 2004) , and are specific to schizophrenia, as compared with other psychotic disorders (Altshuler et al. 2004) , which thus meets the criteria for an endophenotype (Gottesman and Gould 2003) . We reasoned that such abnormalities reflect patterns of deficit across multiple cognitive functions and domains; therefore, searching for distinct illness subtypes on the basis of a single or a few such traits is unlikely to produce coherent results, because of small individual effect sizes and the extraordinary variability that characterizes the cognitive performance of patients with schizophrenia (Heinrichs 2004 ). We adopted a novel phenotyping strategy, aiming to identify composite profiles of cognitive performance. We employed a battery of tests (Hallmayer et al. 2003) , targeting different neurocognitive domains, neurobehavioral features, and selected personality traits.
The study included a total of 531 Western Australian subjects of European descent: 388 members of 112 families affected by schizophrenia and 143 population controls. The families were ascertained through affected probands by monitoring of consecutive admissions to a psychiatric hospital. Probands and first-degree relatives underwent a diagnostic assessment based on a structured interview with the use of Schedules for Clinical Assessment in Neuropsychiatry (SCAN), version 2.0 (Wing et al. 1990 ), a review of case records, and a structured developmental history obtained from a key family member. Full pedigree descriptions and family histories were collected using the National Institute for Mental Health Family Interview for Genetic Studies. Research diagnoses were established by consensus between two senior clinicians (blinded to family relatedness), who reviewed independently all diagnostic information, including the videotape of the SCAN interview, and assigned ICD-10 and DSM-IV lifetime diagnoses. The 388 family members (of whom 145 were parents and 131 were siblings of probands) included 138 affected individuals with schizophrenia or schizophrenia spectrum disorders (SZ/ SZS), which include schizoaffective disorder, schizotypal personality disorder, and other nonaffective psychoses. The 143 control subjects (73 females and 70 males), recruited from a list of Red Cross blood donors or by random sampling from local telephone directories, were screened for psychopathology and were excluded if they or any of their first-degree relatives had been diagnosed with SZ/SZS or bipolar affective disorder. Written informed consent was obtained from all participants. The study complied with the ethics guidelines of the institutions involved.
All 531 participants were administered a battery of tests that assessed performance across seven domains of neurocognitive function, for which evidence of heritability (Cannon et al. 2000) and acceptable effect sizes of test measures (Heinrichs and Zakzanis 1998) have been reported. The domains and corresponding tests were as follows.
General cognitive ability:
The National Adult Reading Test (NART), which estimates prior or premorbid verbal IQ, and the Shipley Institute of Living Scale, which estimates current IQ (by conversion to a Wechsler Adult Intelligence Scale R [WAIS-R] score).
Sustained attention: Two versions of the visual Continuous Performance Task-the degraded-stimulus version (CPT-DS), which involves an increased demand on visual encoding, and the identical-pairs version (CPT-IP), which selectively engages working memory.
Executive function: The FAS version of the Controlled Oral Word Association Task, which tests verbal fluency.
Verbal memory: The Rey Auditory Verbal Learning Test, which measures immediate and delayed recall of word lists, retention after distraction, and errors (i.e., intrusions of nonlist words).
Speed of information processing: The Inspection Time (IT) task, which provides a measure of perceptual encoding and speed of processing, unconfounded by motor-reaction time.
Neurobehavioral features: A structured examination that evaluated a range of soft neurological signs; in addition, The Edinburgh Handedness Inventory of hand/ foot/eye preferences.
Personality factors: The Schizotypal Personality Questionnaire (SPQ) (Raine 1991) and the Temperament and Character Inventory (TCI) (Cloninger and Svrakić 1994) , both of which were completed by all participants.
We used grade of membership (GoM) analysis (Woodbury et al. 1978; Manton et al. 1994) to analyze the test results, with control individuals providing the baseline data. GoM is a form of latent structure analysis, directed at defining a parsimonious number of latent groups or patterns of responses (representing, e.g., biological processes or phenotypes) from complex data sets, and allowing individuals to resemble each group to varying degrees (rather than classifying them into mutually exclusive clusters, as done in standard latent class analysis). These properties enable GoM to account for individual heterogeneity under conditions of high dimensionality better than alternative methods do, as is the case with the multiple continuous cognitive traits we measured for schizophrenia in a modestly sized family sample. Two sets of parameters are estimated by maximum likelihood (Woodbury et al. 1978; Manton et al. 1994) . One set represents the latent pure-type groups by the probabilities ( ) that a subject matching the kth group will l kjl exhibit the ith response for the jth variable. The other set represents the resemblance of individuals to the for the CD trait and 1.000 for the CS trait.
groups by GoM weights ( ), which range from 0 to 1, g ik are constrained to sum to 1 over the groups for each subject, and measure the degree to which the ith subject resembles the kth pure type. The probability that the ith subject has the lth level of the jth variable is defined by a binary variable (i.e., or 1). As a taxometric y p 0 ijl procedure, GoM differs from other clustering or factor analytical methods in that the scores retain full ing ik formation on individuals and account for all individual heterogeneity in the data. By assigning a single score g ik to an individual's GoM in each multivariate pure type, the analysis avoids the problem of multiple testing and the concomitant loss of power due to an increasing number of degrees of freedom. GoM is independent of distribution assumptions and is relatively robust to missing data. In genetic analysis, it combines multivariate continuous trait variables with different effect sizes or heritabilities, resulting in increased power (Kaabi and Elston 2003) .
We used the neurocognitive test results, neurobehavioral features, and personality traits as internal variables to estimate the model parameters. Disease status, position within the pedigree, and demographic information were used descriptively as external variables to provide estimates of their frequencies for each pure type, conditioned on the model parameters. The data in this study were analyzed using the beta 1.01 version of the DSIGoM software (Decision Systems).
Optimal partitioning of the data (by a maximum-likelihood criterion) was obtained with four pure types. Two of these types, referred to as "cognitive deficit" (CD) and "cognitively spared" (CS), displayed markedly contrasting profiles (table 1) , with probabilities of 80.6% (CD) and 70.0% (CS) of being expressed in subjects with SZ/SZS and in a proportion of their unaffected relatives. The CD pure type was characterized by a high probability of poor performance on the majority of cognitive tasks, an increased prevalence of nonlocalizing ("soft") neurological signs, and non-right-handedness (table 1) . The CS pure type exhibited high scores for psychometric schizotypy and for traits associated with psychosis proneness. The remaining two pure types (cognitively intact and cognitively preserved) had little chance (5% and 7%, respectively) of expression in affected subjects and were represented mainly by well-functioning siblings, unaffected parents (some with mild, age-related cognitive nonoptimality), and controls. We used the individual-level GoM coefficients (i.e., scores, which, for each subject, ranged from 0 to 1 g ik for each pure type and summed to 1 over the four pure types) to classify the probands on the basis of the g ik score indicating their greatest affinity to one of the pure types: predominantly CD (41 subjects), CS (51 subjects), or non-CD/CS (20 subjects with low scores for both CD and CS pure types). On the basis of the proband's predominant phenotype assignment, we classified the families into CD, CS, and non-CD/CS groups and examined the familial aggregation of the scores as continug ik ous variables. Intrafamilial aggregation was significant (analysis of variance [ANOVA] ; ) in F p 1.67 P ! .001 the families with the proband assigned to the CD group but not in the families with the proband assigned to the CS or non-CD/CS group (table 2). Next, we analyzed the association of the scores for the CD and CS traits, g ik as continuous variables, with clinical illness (SZ/SZS) in family members. The results ( fig. 1 ) indicated an association of the CD trait with SZ/SZS at all cut-off g ik points у0.3, supporting cosegregation of the CD trait with the clinical phenotype. Finally, to estimate the relative risk ratio (l r ), we compared the prevalence of the CD and CS types among the first-degree relatives of probands and among controls. For the CD type, the prevalence was 18.9% among relatives and 2.0% among controls, yielding . By contrast, the CS preval p 9.5 r lence was 16.8% among relatives and 14.0% among controls, yielding for this type.
The identification of generalized pervasive CD as an endophenotype in some, but not all, subjects SZ/SZS and their families suggested that it might characterize a genetically distinct schizophrenia subtype. To test this hypothesis, we conducted a whole-genome scan, with 380 microsatellites from the LMS1-HD5 marker set (Applied Biosystems), providing an average intermarker distance a Measures of neurocognitive domains, neurobehavioral features, and personality factors were used as internal variables defining the pure types (the cut-off values for each test were the upper and lower bounds of the extreme quantile of the distribution of test scores). The external variables of the pure types are similarly described by probabilities but were not l k used in the identification of the pure types. dL p signal-detection index; LQ p lateralization quotient (by Edinburgh Handedness Inventory).
b Pure types are extreme profiles, partitioning the data in accordance with a maximumlikelihood criterion, and are described by percent probabilities ( ) that an individual exl k pressing completely a given pure type will exhibit the characteristic.
c Age-related. of which had been assigned to the CD subtype), with a total of 342 fully characterized members, including 140 classified as "affected"-117 with the diagnosis of SZ/ SZS and 23 nonpsychotic relatives with the CD phenotype. Linkage analysis was performed with the program package GENEHUNTER-PLUS (Kong and Cox 1997) . We used diagnosis and neurocognitive profile as a bivariate phenotype. For the nonparametric linkage analysis, all individuals with a SZ/SZS diagnosis, as well as clinically unaffected relatives classified by GoM as either CD or CS subtype, were considered to be affected. Multipoint nonparametric LOD (NPL) scores were calculated with the Spairs statistic and a linear model ( fig.  2, left panels) . The data were assessed further using ordered subset analysis (OSA) (Hauser et al. 2004) , in which the proband's score for subtype CD was used g ik as a continuous trait covariate to rank the families in descending order from highest to lowest CD score ( fig.  2, right panels) . OSA identifies the rank-ordered subset of families that provide maximal evidence for linkage (and no a priori specification of the subset is required). The statistical significance of the change in the LOD score between the subset and the overall sample (DLOD) is evaluated by a permutation test as described elsewhere (Hauser et al. 2004) .
The greatest increase in the LOD score detected by NOTE.-Maximum LOD scores and DLOD from baseline for each chromosome, calculated by OSA in family subgroups identified by ordering the family LOD scores from highest to lowest, on the basis of the GoM coefficients (g ik scores) for the CD type. The baseline LOD score is defined as the LOD score summed over all families, and it is the difference between the maximum LOD and DLOD. NA p none of the data sets produced a maximum LOD score greater than the baseline. Key results are shown in bold italics.
a Denotes the maximum LOD score of all ordered subsets of families.
OSA (table 4) was in the 6p24 region, where a maximum LOD of 3.07 and DLOD of 1.546 ( ) were ob-P ! .01 tained at marker D6S309 (20.25 cM). The result was accounted for by the families ranked from 1st to 47th by the proband's score for CD (range 0.884-0.306). g ik In addition to the 34 families classified by GoM as subtype CD, the 47 OSA-positive families included 11 families assigned to the CS subtype and 2 families assigned to the non-CD/CS subtype ( fig. 3A) . Thus, the GoM endophenotype grouping done prior to analysis, for which a stringent cut-off value for CD was applied, proved to be significantly predictive of the observed linkage to 6p, correctly classifying 72.3% of the OSA-positive families and 100% of the OSA-negative families (86.0% correct classification overall).
To corroborate further the prediction that the CD subtype is genetically distinct, we performed parametric multipoint linkage analysis, assuming a CD-susceptibility allele of dominant inheritance. The gene frequency was set at 0.02, with penetrance values of 0.5 for heterozygote and homozygote disease-allele carriers and 0.001 for noncarriers. In these calculations, individuals with no SZ/SZS diagnosis and a CD score of 0 were considered to be unaffected. We genotyped 15 additional microsatellite markers across the 6p25-22 region (average distance 1.72 cM) and analyzed the entire chromosome 6 (with 52 markers) separately for the 47 OSApositive families and the remaining 46 families. This analysis revealed clear differences between the two sets of families ( fig. 3B ). The combined maximum LOD score for the 47 families in the CD group increased to 3.32, again at marker D6S309. By contrast, for the remaining families, linkage was excluded for the entire region, and the LOD score at D6S309 was Ϫ2.12.
Our linkage findings coincide precisely with the strongest signal on 6p25-p22 reported previously (Straub et al. 1995) in a large sample of high-density Irish families with schizophrenia. A follow-up study of the same sam-
Figure 3
Genetic findings for chromosome 6p in 93 fully characterized families with schizophrenia. A, Classification of the families as linked or not linked to the 6p24 locus by OSA of the genome scan data, with use of the proband's score for the CD type as a conting ik uous trait covariate. The positive linkage signal was accounted for by the 47 families (encircled by the dashed line) with the highest scores g ik for the CD subtype. B, Linkage curves for chromosome 6p produced by parametric linkage analysis, conducted separately for the CD-subtype and CS-subtype families. Fine mapping of the 6p25-22 region was done with the addition of 15 microsatellite markers, resulting in an average intermarker distance of 1.72 cM. The CD-subtype families had a LOD score of 3.32 at marker D6S309. At that position, non-CD-subtype families (including the CS and non-CS subtypes) had a LOD score of Ϫ2.12. In the non-CD-subtype families, linkage was excluded for the entire 6p region.
ple suggested that the region might, in fact, contain two schizophrenia-susceptibility genes (Straub et al. 2002b) . After the reported association of SNPs in the DTNBP1 gene on 6p22 (Straub et al. 2002a) , further studies have focused on replication and additional association analyses (reviewed by Owen et al. [2004] ), leaving the 6p25-24 region unexplored. Our results, combined with previous findings (Straub et al. 1995 (Straub et al. , 2002b Bailer et al. 2000; Hwu et al. 2000) , lead us to suggest that it is the CD schizophrenia subtype that accounts for the linkage of schizophrenia to chromosome 6p25-24 and that the region contains a novel susceptibility gene of relatively strong effect.
A post hoc comparison between the OSA-positive families in the CD group and the OSA-negative families in the CS and non-CD/CS groups ( fig. 4) indicated that SZ/SZS-affected subjects did not differ significantly with regard to age at onset or to duration or severity of clinical illness, which argues against the idea that CD and CS subtypes are different stages of a single disease process. However, the comparison did reveal differences in terms of diagnosed psychopathology; "core" schizophrenia was more common among the affected members of the OSA-positive families, with a ratio of core schizophrenia cases to schizophrenia spectrum disorder cases (SZ:SZS) of 2.9 in the OSA-positive families, compared with an SZ:SZS ratio of 2.1 in the OSA-negative families. Further, a greater percentage (12%) of first-degree relatives in the OSA-negative families had experienced episodes of bipolar or recurrent depressive disorder, compared with the percentage of relatives in the OSApositive families (6%), suggesting heterogeneity and susceptibility to both schizophrenia and mood disorders in the CS-subtype families. As expected, the most salient differences between the two groups were related to cognitive function ( fig. 4) , with the CD-subtype families showing lower scores for general cognitive ability, memory, executive function, sustained attention, and speed of information processing. Post hoc logistic regression analysis (by Wald's backward stepwise method) identified verbal memory deficits (delayed word recall), poor sustained attention (by CPT-DS), and estimated current and previous IQ (by NART), as the four neurocognitive parameters (all significant at ) that together clas-P ! .01 sified correctly 91.8% of probands (combined sensitivity 91.2%; specificity 92.3%) as subtype CD or CS, suggesting that, in future genetic studies, efficient endophenotype ascertainment may be possible with an abbreviated neurocognitive-screening battery.
Having identified a cognitive subtype of schizophrenia linked to the 6p25-22 region, we acknowledge the limitation of the modest sample size in the present study as a constraint on our effort to have a more comprehensive characterization of a range of possible neurocognitive endophenotypes in this disorder. The apparent lack of familiality in the CS subtype is attributable to further heterogeneity and insufficient power to resolve familial aggregation, as a result of smaller effect sizes of the personality-trait measures defining this endophenotype (in contrast to relatively large effect sizes for the neurocog-
Figure 4
Post hoc phenotypic comparisons of the families included in the genome scan and OSA and averaged test performance profiles of the members ( ) of the 93 families included in the genome scan and OSA. The differences (by t test) between CD-subtype and nonn p 342 CD-subtype (including the CS and non-CS subtypes) families were significant for previous or premorbid IQ, verbal memory, and sustained attention ( ); verbal fluency ( ); speed of information processing ( ); and non-right-handedness ( ). Neurocognitive P ! .001 P ! .01 P ! .05 P ! .05 domains: 1 p previous or premorbid IQ; 2 p current IQ; 3 p verbal memory, immediate recall; 4 p verbal memory, delayed recall; 5 p verbal fluency; 6 p sustained attention CPT-IP/dL; 7 p sustained attention CPT-DS/dL; 8 p slow information processing (by IT task). Neurobehavioral features: 9 p neurological soft signs; 10 p handedness (lateralization quotient). Personality traits: 11 p schizotypal symptoms; 12 p harm avoidance; 13 p self-transcendence; 14 p self-directedness.
nitive markers identifying the familial CD endophenotype). Future studies should investigate the cognitive architecture of the CS group in greater detail. This group is characterized by more complex symptomatology (systematized delusions, abnormalities of high-order reasoning, etc.) than is the CD group, reflecting a plausible distinction between the two groups in terms of pervasively reduced cognitive efficiency in CD-subtype individuals versus dysfunctional cognitive control in the CS-subtype individuals (a similar distinction has been proposed by Brebion et al. [2005] ). Although powerful enough for reliable assessment of reduced cognitive efficiency, our present battery of tests may not be targeting the essential features of a putative CS endophenotype likely to display abnormalities in complex functions, such as self-monitoring, source attribution, and cognitive inhibition, as well as in their modulation by external (environmental) and internal (affective) background factors.
Notwithstanding such caveats, our data bring back to center stage the critical issue of phenotypic and etiological diversity in schizophrenia. The neurocognitive tests that we used to dissect the disease phenotype outlined a relatively homogeneous, familial, genetically distinct subtype closely corresponding to the dementia praecox described by Kraepelin (1909) . In our sample, this subtype accounted for ∼30% of families on the basis of the more stringent cut-off value in our GoM analysis and for g ik up to ∼50% of families on the basis of the OSA of the linkage data. If this sample is representative of other European populations, the observed prevalence of disease subtypes would have serious implications for the power of genetic studies-traditionally based on broad DSM-IV and ICD-10 diagnostic categories-to detect linkage and association. Parsing the phenotypic complexity of schizophrenia may open the way to a more informed search for specific pathogenetic pathways and underlying genetic mechanisms. Neurocognitive profiling with the proposed abbreviated battery, which comprises the most informative tests, should facilitate research, focusing on a more crisply defined, familial subtype of schizophrenia.
